Thomas M. Wheeler, MD, Author at Grand Rounds in Urology

Thomas M. Wheeler, MD

Sagis Diagnostic Pathology

Houston, Texas

Thomas M. Wheeler, MD, is the Head of Surgical Pathology and Cytopathology at Sagis Diagnostic Pathology in Houston, Texas. Dr. Wheeler earned his medical degree from Baylor College of Medicine and completed his residency and fellowship at Baylor College of Medicine’s affiliate hospital. He is certified in anatomic and clinical pathology and cytopathology by the American Board of Pathology. In addition to surgical pathology and cytopathology, he specializes in urologic and thyroid diagnostics. Dr. Wheeler has published over 350 works and is interested in clinicopathological correlations, including evaluating biomarkers in prostate carcinoma. Dr. Wheeler served as a member of the Board of Governors for the College of American Pathologists from 2003-2009. He also served as the President of the Texas Society of Pathologists, the Texas Society of Cytology, and the Houston Society of Clinical Pathologists. His previous positions include serving as Senior Vice Chair for the W.L. Moody, Jr. Faculty Practice Pathology Group, Distinguished Emeritus Professor and Immediate Past Chair of the Department of Pathology & Immunology at Baylor College of Medicine, and Member of the Dan L. Duncan Comprehensive Cancer Center at Baylor College of Medicine.

Disclosures:

Talks by Thomas M. Wheeler, MD

Prostate: Anatomic Considerations

Posted by Thomas M. Wheeler, MD | Jan 2024

Thomas M. Wheeler, MD, presents anatomic considerations relating to the prostate and prostate cancer for clinicians. He begins by illustrating why prostate cancer rarely metastasizes via the neighboring rectum, usually spreading to the rest of the body via the neurovascular bundle.

Dr. Wheeler then presents a few examples of prostate cancer, noting that most prostate cancer is multifocal. He presents multiple cross-sections of prostate cancer to illustrate the differences between multifocal cancer, index cancer, and large volume unifocal prostate cancer.

Dr. Wheeler concludes by reviewing the history of differentiating prostate zones, tumor volume and Gleason scores in prostate cancer, and what they indicate in patient prognosis. He notes that levels of capsular invasion, perineural invasion diameter, and presence of intraductal carcinoma are all significant prognostic indicators.

Prostate Anatomy and Clinical Pathologic Considerations

Posted by Thomas M. Wheeler, MD | Mar 2023

Thomas M. Wheeler, MD, provides an anatomic perspective of prostate cancer diagnosis and movement prediction.